Screening for hepatocellular carcinoma: From lack of evidence to common sense

Hepatology

Volumn 52, Issue 5, 2010, Pages 1863-1864

  Braillon, Alain ^a  

^a AMIENS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B VACCINE;

ALCOHOL CONSUMPTION; CANCER EPIDEMIOLOGY; CANCER RISK; CANCER SCREENING; CIGARETTE SMOKING; COST EFFECTIVENESS ANALYSIS; EVIDENCE BASED PRACTICE; GASTROENTEROLOGIST; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LETTER; LIVER CELL CARCINOMA; MEDICAL SPECIALIST; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUALITY CONTROL; RELIABILITY; RISK FACTOR; SMOKING CESSATION; SURVIVAL TIME;

CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; MASS SCREENING; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT;

EID: 78049526500     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23780     Document Type: Letter

References (10)

1. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. HEPATOLOGY 2010; 52: 132-141.
2. Bruix J, Sherman M. Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. HEPATOLOGY 2005; 42: 1208-1236.
3. Trevisani F, Santi V, Gramenzi A, Di Nolfo MA, Del Poggio P, Benvegnù L, et al.; Italian Liver Cancer Group. Surveillance for early diagnosis of hepatocellular carcinoma: is it effective in intermediate/advanced cirrhosis? Am J Gastroenterol 2007; 102: 2448-2457.
4. Braillon A, Nguyen-Khac E. Hepatocellular carcinoma: a pledge for evidence-based medicine. Am J Med 2008; 121: e7.
5. Kemp W, Pianko S, Nguyen S, Bailey MJ, Roberts SK. Survival in hepatocellular carcinoma: Impact of screening and etiology of liver disease. J Gastroenterol Hepatol 2005; 20: 873-881.
6. Braillon A. Screening for hepatocellular carcinoma: still in search for evidence based medicine? J Gastroenterol Hepatol 2006; 21: 1355-1356.
7. National Cancer Institute, U.S. National Institutes of Health. Liver (hepatocellular) cancer screening (PDQ®). Accessed May 2010.
8. U.S. Institute of Medicine. A national cancer clinical trial system for the 21st century: reinvigorating the NCI Cooperative Group Program. Accessed May 2010.
9. Jee SH, Ohrr H, Sull JW, Samet JM. Cigarette smoking, alcohol drinking, hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst 2004; 96: 1851-1856.
10. Dubois G, Braillon A. Hepatocellular carcinoma: again, tobacco is the first enemy. Int J Epidemiol 2009; doi:10.1093/ije/dyp352.